4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001904824-26-000002
Options or other derivatives
- Chief Scientific Officer acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Smeal Tod Chief Scientific Officer | 2026-04-14 | Grant or award · Stock Options | +300,000 | 1,279,805 | D | ||
Loading xslF345X06/ownership.xml…